A Clinical Investigation Evaluating and Understanding Parameters Affecting the Performance of Ostomy Products
NCT ID: NCT02517541
Last Updated: 2022-11-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
74 participants
INTERVENTIONAL
2015-09-30
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of a New 1-piece Convex Ostomy Product
NCT02043782
A Clinical Investigation of New Ostomy Appliances
NCT01523756
Investigation of Three Newly Developed 2-piece Convex Base-plates in Subjects With Ileostomy
NCT01957397
Investigation of Two Newly Developed 2-piece Convex Baseplates in Subjects With Ileostomy
NCT01957475
Study Evaluating a New Ostomy Appliance With Regard to Leakage, Handling and Comfort
NCT01243294
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Coloplast will provide SenSura Mio Convex Soft for all subjects via the investigator. Based on the subjects' usual changing pattern, the investigator will provide the subjects with enough products for the whole test period.
The subject will answer questions regarding the tested products by filling out the subject part in the eCRF daily. The subject will answer questions using an electronic device and use the device to take pictures of the peristomal skin and used products at each product change. The Investigator fills out the investigator part of the eCRF at each visit. The subjects must complete the general questions at the end of each test period before their second and third visit at the Clinic/hospital or at home to avoid influence by the investigator.
The use of accessories will be noted in the eCRF. Samples of biological material will not be taken or used in this investigation. Patient files from own physician will not be used for subjects recruited via a Coloplast's database. The investigators may use patient files for subjects recruited via hospital sites/ostomy clinics to identifying relevant subjects and/or to verify baseline information, concomitant medication or adverse events. To be able to fulfil the objectives, the investigation must include both ileostomists and colostomists.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test period
The arm consists of a two-week baseline period where subjects apply their own product and a 12 weeks test period where the subjects apply the intervention (SenSura Mio Convex Soft)
SenSura Mio Convex Soft
SenSura Mio Convex Soft is a CE marked ostomy product manufactured by Coloplast
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SenSura Mio Convex Soft
SenSura Mio Convex Soft is a CE marked ostomy product manufactured by Coloplast
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be at least 18 years of age and have full legal capacity
* Have an ileostomy or colostomy
* Have had their ostomy for at least 3 months
* Must use 1 piece open or closed ostomy products during the test period
* Currently using a 1 piece. flat product
* Must be able to use custom cut product
* Have intact peristomal skin
* Has experienced leakage (seeping) under the baseplate at least three times during the last two weeks
* Are evaluated to be suitable for a soft convex product
Exclusion Criteria
* Currently or having within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment.
* Are pregnant or breastfeeding
* Participating in other interventional clinical investigations or have previously participated in this investigation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coloplast A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Camilla F Vibjerg, M.Sc.pharm
Role: STUDY_CHAIR
Head of Clinical Operations
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Chicago Medicine
Chicago, Illinois, United States
Prism research center
Saint Paul, Minnesota, United States
QPS Netherlands
Groningen, , Netherlands
Helse Nordbyen
Larvik, , Norway
Synexus Midlands
Birmingham, , United Kingdom
Pilgrim Hospital
Boston, , United Kingdom
Cheltenham General Hospital
Cheltenham, , United Kingdom
Kettering General hospital
Kettering, , United Kingdom
Lincon Country hospital
Lincoln, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP259
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.